Positive Top-Line Results from Oramed’s Oral Insulin Drug Phase 2 NASH Trial
Oramed Pharmaceuticals Inc. ( Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today positive Phase 2 results from its…
Continue Reading
Positive Top-Line Results from Oramed’s Oral Insulin Drug Phase 2 NASH Trial